ImmuCell (ICCC)
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that improves the health and productivity of dairy and beef cattle in...
- Open
- 11.098
- High
- 11.098
- Low
- 10.865
- Prev. Close
- 11.000
- Volume
- 12.15K
- Turnover
- 133.06K
- Avg Price
- 10.953
- Bid/Ask Ratio
- --
- Amplitude
- 2.12%
- 52wk High
- 12.100
- Volume Ratio
- 0.73
- Turnover Ratio
- 0.20%
ImmuCell Analyst Rating
View moreForecast & Rating
Oct 6, 2020Price forecast
$14.0027.62%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Aug 6 at 03:50 PM
ImmuCell updates financial calendar with quarterly results release and investor call
- rttnews · Jul 13 at 06:18 AM
Biotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH
- Earnings Watch · Jul 9 at 03:10 PM
ImmuCell | 8-K: FY2026 Q2 Revenue: USD 7.2 M
- PUBT · Jul 9 at 03:06 PM
ImmuCell Q2 product sales rise 11.5% to $7.2 million on preliminary results
- Tip Ranks · Jun 22 at 09:07 PM
Immucell CEO Makes Bold Move With Significant Personal Stock Purchase
- PUBT · Jun 22 at 07:34 AM
ImmuCell CEO Paul te Boekhorst buys 8,000 shares for $75,960
